AzTrials
AzTrials

Congenital Heart DiseaseNCT04264650

Effectiveness of an mHealth Intervention for Youth With Congenital Heart Disease

A study testing an mHealth intervention in people with Congenital Heart Disease and Adolescent Behavior, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aims of this study were to evaluate the long-term effectiveness of the Care \& Organize Our Lifestyle (COOL) program, a self-regulation theory-based mHealth program, on improving disease knowledge and physical activity in youth with congenital heart disease (CHD). Read more about this study

Who is it for?
Ages 15 to 24 years
Conditions the study is for
Congenital Heart Disease, Adolescent Behavior
What is being tested?
an mHealth intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
143 participants
Where
1 siteTaiwan
Study dates
1 Jun 2016to 28 Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 24 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • being diagnosed with CHD by a pediatric cardiologist and qualifying as having simple or moderate CHD complexity according to the 2008 American College of Cardiology/American Heart Association guidelines;
  • having a regular pulse;
  • being 15-24 years of age;
  • being conversant in Mandarin and Taiwanese;
  • possessing a smartphone with Internet connection;
  • agreeing to wear an exercise-monitoring wristband to record physiological data;
  • agreeing to engage in exercises designed to test cardiopulmonary endurance;
  • agreeing to participate in the study and sign an informed consent form for a relevant interview. For participants under 20 years of age, guardian approval by signing a written consent form was required.

Who cannot join

  • having cognitive impairment to the extent of being noncommunicative;
  • having CHD complicated with other congenital abnormalities;
  • having undergone a cardiac catheter-related intervention or surgery within the past 6 months;
  • being pregnant

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National Yang-Ming University

    Taipei, 11221

Other trials in Taiwan

About this study

Official title: Long-term Effectiveness of an mHealth Intervention for Improving the Disease Knowledge and Physical Activity of Youth With Congenital Heart Disease: A Randomized Controlled Trial

The aims of this study were to evaluate the long-term effectiveness of the Care \& Organize Our Lifestyle (COOL) program, a self-regulation theory-based mHealth program, on improving disease knowledge and physical activity in youth with congenital heart disease (CHD). The COOL program is a 12-month randomized controlled trial that compared two active intervention groups to a standard-care control group (n = 47). Participants with simple and moderate CHD aged 15-24 years were recruited from pediatric or adult CHD outpatient departments. Participants in one active intervention group (n = 49) were provided with COOL Passport, a mobile healthcare application. Those in the other group (n = 47) were provided with access to the Health Promotion Cloud system and use of game-based interactive platforms along with COOL Passport. Outcomes were the Leuven Knowledge Questionnaire for CHD and the International Physical Activity Questionnaire-Taiwan Show-Card Version.

Read the detailed description

Background: Mobile health initiatives may provide youth with congenital heart disease (CHD) relevant health information and a platform for managing the complex health care needs associated with undergoing transitional care.

Aims: To evaluate the long-term effectiveness of the Care \& Organize Our Lifestyle (COOL) program, a self-regulation theory-based mHealth program, on improving disease knowledge and physical activity in youth with CHD.

Methods: The COOL program is a 12-month randomized controlled trial that compared two active intervention groups to a standard-care control group (n = 47). Participants with simple and moderate CHD aged 15-24 years were recruited from pediatric or adult CHD outpatient departments. Participants in one active intervention group (n = 49) were provided with COOL Passport, a mobile healthcare application. Those in the other group (n = 47) were provided with access to the Health Promotion Cloud system and use of game-based interactive platforms along with COOL Passport. Outcomes were the Leuven Knowledge Questionnaire for CHD and the International Physical Activity Questionnaire-Taiwan Show-Card Version.

Being tested
an mHealth intervention
Medical subject headings
Heart Defects, Congenital, Adolescent Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • an mHealth interventionBehavioural

    The Care \& Organize Our Lifestyle (COOL) program, a self-regulation theory-based mHealth program

Study groups in NCT04264650
Study groupRoleWhat they receive
Control groupNo interventionStandard care
One active intervention groupExperimentalprovided with COOL Passport, a mobile healthcare application
Receives: Behavioral: an mHealth intervention
The other active intervention groupExperimentalprovided with access to the Health Promotion Cloud system and use of game-based interactive platforms along with COOL Passport
Receives: Behavioral: an mHealth intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiac disease knowledge

    measured by the Leuven Knowledge Questionnaire for CHD

    Measured: 12 months

Secondary outcomes (1)
  1. Physical activity

    measured by the International Physical Activity Questionnaire-Taiwan Show-Card Version

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2020
  2. Study start1 Jun 2016
  3. Primary completion28 Feb 2018
  4. Study completion28 Feb 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
143 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04264650
Sponsor's protocol ID
201603045RINA
Status last verified
Feb 2020
First submitted
9 Feb 2020
Last updated
11 Feb 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lin PJ, Fanjiang YY, Wang JK, Lu CW, Lin KC, Cheong IM, Pan KY, Chen CW. Long-term effectiveness of an mHealth-tailored physical activity intervention in youth with congenital heart disease: A randomized controlled trial. J Adv Nurs. 2021 Aug;77(8):3494-3506. doi: 10.1111/jan.14924. Epub 2021 Jun 21.

    PubMed 34151444
  • Williams CA, Wadey C, Pieles G, Stuart G, Taylor RS, Long L. Physical activity interventions for people with congenital heart disease. Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD013400. doi: 10.1002/14651858.CD013400.pub2.

    PubMed 33112424

Questions about this trial

What is this clinical trial studying?

A study testing an mHealth intervention in people with Congenital Heart Disease and Adolescent Behavior, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiac disease knowledge (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04264650, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in